A delivery is not an administrative afterthought in a controlled laboratory. It is the first defensible record that links a catalogue item, a batch label, storage conditions and an intended in-vitro research use. When a laboratory SOP is updated, the refund pathway should be written at the receiving bench, not left in a finance folder. That is especially important for research-use-only materials, where the supplier’s published position is clear: no returns once dispatched, because of the specialist and perishable nature of the goods; refunds are considered only for damage, incorrect supply or quality issues, as set out in the Refunds & Returns Policy. The SOP should tell staff how to recognise those three conditions, what to record before a vial is moved, and when to contact the supplier. It should also state that all materials are for controlled laboratory and analytical research only, and are not for human or veterinary use.
Why the Refund Schedule Belongs in the Receiving SOP, Not the Finance Folder
Refund eligibility is usually decided long before a finance query is raised. It is decided at receipt, when the outer box is still intact, the label is legible and the vial has not been opened. If the laboratory SOP only says “report damages to finance”, staff may discard packaging, move a compromised vial into general storage, or miss the batch reference that connects the item to its CoA. A better SOP adds a short, mandatory receiving stage: inspect, record, quarantine where needed, and route the case as damage, incorrect supply or quality issue. The supplier’s published policy permits refunds only for those categories; it does not create a general right of return. Writing that distinction into the SOP prevents well-meaning staff from promising a return that the supplier’s terms do not support.
The receiving stage should be written for a laboratory, not a warehouse. All materials are research-use-only and not for human or veterinary use. If a vial is cracked, leaking or visibly compromised, local safety and COSHH procedures take priority. Do not open or handle a damaged vial outside appropriate containment merely to obtain a photograph. Record what can be seen safely, preserve the outer packaging and quarantine the consignment according to local rules. For intact deliveries, check the label reference against the order record. The supplier describes vial labels using a SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. That reference is more useful than a generic product name. The SOP should require it to be entered into the receiving log alongside the order number, catalogue item, quantity received and any visible packaging defect. The supplier’s current published catalogue and terms can be reviewed via Peptide uk, but the SOP itself should cite the live Refunds & Returns Policy rather than an old printout.
Three Evidence Streams: Damage, Incorrect Supply and Quality Deviations
The SOP should use three evidence streams because the supplier’s refund policy uses three categories. Treating them as one “problem order” bucket weakens the record and makes it harder to distinguish a transit issue from a catalogue discrepancy or a documented quality concern. Each stream needs its own trigger, evidence fields and escalation note. The common rule is that the laboratory records facts, not conclusions: “outer carton crushed and vial B visibly cracked” is stronger than “damaged peptide”. Equally, staff should avoid asserting a quality failure before checking the batch CoA and the published product description. The supplier’s homepage lists independently verified compounds, transparent CoAs and “CoAs Janoshik Analytical Reports”; the researcher’s task is to open and check the CoA that accompanies the specific batch, not to rely on a headline purity figure.
For damage, the SOP can require safe visual inspection of outer packaging, internal protection and vial integrity. Record the order number, label reference, affected SKU, visible defect and whether the packaging was photographed before opening. If local rules allow, retain packaging and any desiccant or temperature-aware packing materials as evidence. Do not place a compromised vial into storage with usable stock. Quarantine it and mark it clearly under the laboratory’s deviation system. Because the materials are not for human or veterinary use, no one should attempt to salvage or test a damaged vial outside the approved in-vitro workflow. The SOP should say “contact the supplier with the evidence set” rather than “return the item”, because the published policy states no returns once dispatched.
For incorrect supply, the SOP should define a mismatch between the order record and what arrived: wrong catalogue item, wrong SKU, or a documentation mismatch that prevents the batch from being matched to its CoA. Vial cap colour is not an indicator of identity, analytical quality or manufacturing origin; packaging may vary. Staff should verify the label, SKU and CoA reference, not the cap colour. If restocked products carry the same Internal Test Reference (ITR), staff should understand that an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. For quality issues, the SOP should require a documented basis: compare the received item with the batch CoA for purity and identity, and with the published storage and handling guidance. The supplier states that every compound includes a CoA for HPLC purity and identity, and describes full-spectrum testing as covering purity, identity, heavy metals and endotoxin evaluation. Any concern should be logged against the specific batch reference and CoA; do not invent pass/fail limits or extrapolate from another product’s certificate.
Writing the SOP Text: Triggers, Records and Supplier Contact Flow
A practical SOP clause should begin with a clear trigger: “on receipt of any research-use-only consignment, complete the receiving check before storage.” The record should capture the supplier name, order number, catalogue item, SKU, label reference, CoA reference, quantity, visible condition, storage location and the name of the person completing the check. If a deviation is suspected, the SOP should require a quarantine action, a deviation-log entry and a supplier contact note. The contact note should state which of the three published categories applies—damage, incorrect supply or quality issue—and attach the relevant evidence. For quality concerns, include the batch CoA reference and the storage history. For damage, include photographs taken within safety limits. For incorrect supply, include the order record and the label reference. This structure keeps the enquiry focused and avoids speculative claims.
The SOP should also make clear what is not a refund trigger. Delivery times are estimates; the supplier describes next-working-day dispatch and Royal Mail Tracked 24 as an estimate, and the homepage’s “24hr UK Delivery” line should not be treated as a guaranteed arrival promise. A delay alone is therefore not a damage, incorrect-supply or quality case. Payment records should be captured where relevant: the shop states it does not accept card payments and uses Pay-By-Bank / Open Banking, so finance staff should retain the Open Banking reference rather than assume a card-chargeback route. Storage guidance should be repeated in the SOP: lyophilised materials at −20°C or below, sealed with desiccant and protected from moisture, heat and light; reconstituted materials are less stable and should be stored at 2–8°C for short-term laboratory use. All materials remain research-use-only and not for human or veterinary use. The SOP’s final procedural line should require the live Refunds & Returns Policy to be reconfirmed at each review, with the review date recorded in month and year, so that the laboratory’s refund file reflects the supplier’s current published wording rather than an outdated assumption.
